US Patent Issued to BaroPace on July 28 for "Method using trend analysis for cardiac treatment with calibrated and positionally corrected blood pressure watches, pressure-pace algorithms, artificial intelligence and thoracic electrical bioimpedance" (Oregon Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,286, issued on July 28, was assigned to BaroPace Inc. (Ashland, Ore.).

"Method using trend analysis for cardiac treatment with calibrated and positionally corrected blood pressure watches, pressure-pace algorithms, artificial intelligence and thoracic electrical bioimpedance" was invented by Michael Burnam (Ashland, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of using thoracic electrical bioimpedance (TEB) as a component in a real-time closed-loop system to treat drug resistant hypertension (DRH) or diastolic heart failure (called HFpEF in patients with pacemakers using machine learning/AI and an algorithm (PressurePace-see the inco...